Search Within

Santosha Adipudi Vardhana

Formats
  1. Meeting Abstract (53)
  2. Journal Article (37)
  3. Editorial (9)
  4. Research Letter (6)
  5. Review (5)
  6. Conference Paper (2)
Groups
  1. Center for Hematologic Malignancies (112)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (112)
  3. Department of Medicine (112)
  4. GSK Faculty (112)
  5. Hematologic Malignancies, Division of (112)
  6. Human Oncology and Pathogenesis Program (112)

More Groups

People
  1. Alison Moskowitz (45)
  2. Anita Kumar (42)
  3. Steven Horwitz (42)
  4. Andrew Zelenetz (40)
  5. Ariela Noy (38)
  6. Lorenzo Falchi (37)

More People

Years
  1. 2025 (4)
  2. 2024 (25)
  3. 2023 (29)
  4. 2022 (18)
  5. 2021 (13)
  6. 2020 (10)

More Years

Publications
  1. Blood (39)
  2. Journal of Clinical Oncology (10)
  3. Hematological Oncology (5)
  4. Annals of Surgical Oncology (4)
  5. Blood Advances (4)
  6. Annals of Surgery (3)

More Publications

Publishers
  1. American Society of Hematology (43)
  2. American Society of Clinical Oncology (11)
  3. Nature Publishing Group (9)
  4. Cell Press (8)
  5. American Association for Cancer Research (6)
  6. Elsevier Inc. (6)

More Publishers

Results (112)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Disappearing signet ring cell adenocarcinoma in gastric cancer patients
    Journal Article

    Sreeram, A.; Stroobant, E. E.; Laszkowska, M.; Guilford, P.; Shimada, S.; Nishimura, M.; Shah, S.; Vardhana, S.; Tang, L. H.; Strong, V. E.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: A phase 1b/2a trial
    Journal Article

    Horwitz, S. M.; Nirmal, A. J.; Rahman, J.; Xu, R.; Drill, E.; Galasso, N.; Ganesan, N.; Davey, T.; Hancock, H.; Perez, L.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Feasibility and efficacy of sentinel lymph node mapping in gastric cancer
    Journal Article

    Abate, M.; Drebin, H.; Shimada, S.; Fei, T.; McKinley, S.; Poruk, K.; Ferguson, B.; Neuwirth, M.; Tang, L. H.; Vardhana, S.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Consideration of a novel surgical approach in the management of gastric adenocarcinoma and proximal polyposis syndrome
    Journal Article

    Judge, S. J.; Gearty, S. V.; Catchings, A.; Ranganathan, M.; Roehrl, M. H.; Vardhana, S. A.; Tang, L.; Stadler, Z. K.; Strong, V. E.
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis
    Research Letter

    Johnson, W. T.; Epstein-Peterson, Z. D.; Ganesan, N.; Pak, T.; Chang, T.; Dao, P.; Moskowitz, A. J.; Stuver, R. N.; Ghione, P.; Galasso, N.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer (PDAC): Long-term outcomes and correlative insights
    Meeting Abstract

    Keane, F.; Tuli, R.; O'Connor, C. A.; Schwartz, C.; Park, W.; Varghese, A. M.; Perry, M.; Singhal, A.; Vardhana, S.; Hendifar, A. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma
    Journal Article

    Liu, Y.; Sardana, R.; Nemirovsky, D.; Frosina, D.; Jungbluth, A.; Johnson, W. T.; Vardhana, S.; Arcila, M.; Horwitz, S. M.; Derkach, A.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma
    Research Letter

    Stuver, R.; Noy, A.; Vardhana, S. A.; Zelenetz, A. D.; Moskowitz, A. J.
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save